Smarty, maybe you could get your source to issue a "fluff" piece on what all the current disease application identifiers are for Cymerus (including all the “internal planning” ones). Better still, issue them along with the “Corporation Presentations” associated with each.
This may instil some confidence in the long-term suffering shareholders that some sort of progress is being made toward commercialising something.
Because as far as I am aware, CYP-003 has not been mentioned anywhere!
So now we know of CYP-001, CYP-002, CYP-003 and CYP-004.
Be nice to see CYP-005, CYP-006,… CYP-00x announcements over the coming months.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.015(9.68%) |
Mkt cap ! $38.41M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 17.0¢ | 15.5¢ | $47.10K | 289.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 23813 | 3 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |